DOES COMORBID OBESITY OR CHRONIC PANCREATITIS INFLUENCE THE CHOICE AND EFFECTIVENESS OF GLUCOSE-LOWERING THERAPY IN TYPE 2 DIABETIC PATIENTS?

DOES COMORBID OBESITY OR CHRONIC PANCREATITIS INFLUENCE THE CHOICE AND EFFECTIVENESS OF GLUCOSE-LOWERING THERAPY IN TYPE 2 DIABETIC PATIENTS?

Introduction. The complexity of the interaction between type 2 diabetes mellitus (T2DM), comorbidities, and emerging complications requires a clinical approach that manages risk while maintaining indicated therapeutic goals. The objective of the study was to analyse the frequency and effectiveness...

Full description

Bibliographic Details
Main Authors: Mariya MARUSHCHAK, Uliana HEVKO, Inna KRYNYTSKA, Yulia DANYLEVYCH, Svitlana DANCHAK, Lyudmyla MAZUR
Format: Article
Language:English
Published: Balkan Medical Union 2021-03-01
Series:Archives of the Balkan Medical Union
Subjects:
type 2 diabetes mellitus
obesity
chronic pancreatitis
glucose-lowering therapy
effectiveness
Online Access:https://umbalk.org/does-comorbid-obesity-or-chronic-pancreatitis-influence-the-choice-and-effectiveness-of-glucose-lowering-therapy-in-type-2-diabetic-patients/

Internet

https://umbalk.org/does-comorbid-obesity-or-chronic-pancreatitis-influence-the-choice-and-effectiveness-of-glucose-lowering-therapy-in-type-2-diabetic-patients/

Similar Items